Disability and quality of life in post-traumatic stress disorder: Impact of drug treatment

PharmacoEconomics

Volumn 24, Issue 10, 2006, Pages 989-998

  Seedat, Soraya ^a,c   Lochner, Christine ^a   Vythilingum, Bavanisha ^a   Stein, Dan J ^a,b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; NEFAZODONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANXIETY DISORDER; CLINICAL TRIAL; COMORBIDITY; COST BENEFIT ANALYSIS; DAILY LIFE ACTIVITY; DISABILITY; DISEASE SEVERITY; DRUG DOSE REGIMEN; ECONOMIC ASPECT; FUNCTIONAL ASSESSMENT; HEALTH CARE; HUMAN; MENTAL HEALTH; META ANALYSIS; MOOD DISORDER; PATIENT ATTITUDE; PATIENT SATISFACTION; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; DISABLED PERSONS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MORBIDITY; QUALITY OF LIFE; SEX FACTORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 33749345051     PISSN: 11707690     EISSN: 11707690     Source Type: Journal    
DOI: 10.2165/00019053-200624100-00006     Document Type: Review

References (60)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV-TR). 4th ed. Washington, DC: American Psychiatric Press, 2000
2. Stein MB, McQuaid JR, Pedrelli P, et al. Posttraumatic stress disorder in the primary care medical setting. Gen Hosp Psychiatry 2000; 22 (4): 261-9
3. Wolfe J, Proctor SP, Erickson DJ, et al. Relationship of psychiatric status to Gulf War veterans' health problems. Psychosom Med 1999; 61 (4): 532-40
4. Walker EA, Unutzer J, Rutter C, et al. Costs of health care use by women HMO members with a history of childhood abuse and neglect. Arch Gen Psychiatry 1999 Jul; 56 (7): 609-13
5. Koss MP, Koss PG, Woodruff WJ. Deleterious effects of criminal victimization on women's health and medical utilization. Arch Intern Med 1991; 151 (2): 342-7
6. Resnick HS, Acierno R, Kilpatrick DG. Health impact of interpersonal violence: 2. Medical and mental health outcomes. Behav Med 1997; 23 (2): 65-78
7. Walker EA, Katon W, Russo J, et al. Health care costs associated with posttraumatic stress disorder symptoms in women. Arch Gen Psychiatry 2003; 60 (4): 369-74
8. Holbrook TL, Hoyt DB, Coimbra R, et al. Long-term posttraumatic stress disorder persists after major trauma in adolescents: new data on risk factors and functional outcome. J Trauma 2005; 58: 764-71
9. Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry 2000; 157 (5): 669-82
10. Naughton MJ, Shumaker SA. Assessment of health-related quality of life. In: Friedman LM, Furberg CD, DeMets DL, editors. Fundamentals of clinical trials. New York: Springer-Verlag, 1998: 185-203
11. Berzon R, Hays RD, Shumaker SA. International use, application and performance of health-related quality of life instruments. Qual Life Res 1993; 2 (6): 367-8
12. McHorney CA, Ware Jr JE, Raczek AE. The MOS 36-item Short form Health Survey (SF-36), II: psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247-63
13. Sheehan DV. The anxiety disease. New York: Charles Scribner's Sons, 1983
14. Endicott J, Nee J, Harrison W, et al. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull 1993; 29: 321-6
15. Shalev AY. Measuring outcome in posttraumatic stress disorder. J Clin Psychiatry 2000; 61 Suppl. 5: 33-9
16. Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA 2000; 283 (14): 1837-44
17. . EuroQol: a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990; 16 (3): 199-208
18. Thulesius H, Alveblom AK, Hakansson A. Post-traumatic stress associated with low self-rated well-being in primary care attenders. Nord J Psychiatry 2004; 58 (4): 261-6
19. Quilty LC, Van Ameringen M, Mancini C, et al. Quality of life and the anxiety disorders. J Anxiety Disord 2003; 17: 405-26
20. Alonso J, Angermeyer MC, Bernert S, et al.; ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project. Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004; (420): 38-46
21. Wolfe F, Hawley DJ. Measurement of the quality of life in rheumatic disorders using the EuroQol. Br J Rheumatol 1997; 36: 786-93
22. Rothwell PM. Quality of life in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 65 (4): 433
23. Malik ML, Connor KM, Sutherland SM, et al. Quality of life and posttraumatic stress disorder: a pilot study assessing changes in SF-36 scores before and after treatment in a placebo-controlled trial of fluoxetine. J Trauma Stress 1999; 12 (2): 387-93
24. Amir M, Lev-Wiesel R. Time does not heal all wounds: quality of life and psychological distress of people who survived the holocaust as children 55 years later. J Trauma Stress 2003; 16 (3): 295-9
25. Rapaport MH, Clary C, Fayyad R, et al. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry 2005; 162: 1171-8
26. Schelling G, Stoll C, Haller M, et al. Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome. Crit Care Med 1998; 26 (4): 651-9
27. Carlsson JM, Mortensen EL, Kastrup M. A follow-up study of mental health and health-related quality of life in tortured refugees in multidisciplinary treatment. J Nerv Ment Dis 2005; 193 (10): 651-7
28. Sareen J, Stein MB, Campbell DW, et al. The relation between perceived need for mental health treatment, DSM diagnosis, and quality of life: a Canadian population-based survey. Can J Psychiatry 2005; 50 (2): 87-94
29. Laffaye C, Kennedy C, Stein MB. Post-traumatic stress disorder and health-related quality of life in female victims of intimate partner violence. Violence Vict 2003; 18 (2): 227-38
30. Doerfler LA, Paraskos JA, Piniarski L. Relationship of quality of life and perceived control with posttraumatic stress disorder symptoms 3 to 6 months after myocardial infarction. J Cardiopulm Rehabil 2005; 25: 166-72
31. Holbrook TL, Hoyt DB, Stein MB, et al. Perceived threat to life predicts posttraumatic stress disorder after major trauma: risk factors and functional outcome. J Trauma 2001; 51 (2): 287-92
32. Johnsen BH, Eid J, Laberg JC, et al. The effect of sensitization and coping style on post-traumatic stress symptoms and quality of life: two longitudinal studies. Scand J Psychol 2002; 43 (2): 181-8
33. Lecrubier Y. Posttraumatic stress disorder in primary care: a hidden diagnosis. J Clin Psychiatry 2004; 65 Suppl. 1: 49-54
34. Ouimette P, Cronkite R, Henson BR, et al. Posttraumatic stress disorder and health status among female and male medical patients. J Trauma Stress 2004; 17 (1): 1-9
35. Kramer TL, Booth BM, Han X, et al. Service utilization and outcomes in medically ill veterans with posttraumatic stress and depressive disorders. J Trauma Stress 2003; 16 (3): 211-9
36. Mueser KT, Essock SM, Haines M, et al. Posttraumatic stress disorder, supported employment, and outcomes in people with severe mental illness. CNS Spectr 2004; 9 (12): 913-25
37. Gudmundsdottir B, Beck JG, Coffey SF, et al. Quality of life and post trauma symptomatology in motor vehicle accident survivors: the mediating effects of depression and anxiety. Depress Anxiety 2004; 20 (4): 187-9
38. d'Ardenne P, Capuzzo N, Fakhoury WK, et al. Subjective quality of life and posttraumatic stress disorder. J Nerv Ment Dis. 2005; 193 (1): 62-5
39. Schonfeld WH, Verboncoeur CJ, Fifer SK, et al. The functioning and well-being of patients with unrecognized anxiety disorders and major depressive disorder. J Affect Disord 1997; 43 (2): 105-19
40. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study [published erratum appears in JAMA 1989 Nov 10; 262 (18): 2542]. JAMA 1989 Aug 18; 262 (7): 907-13
41. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52 (12): 1048-60
42. Holbrook TL, Hoyt DB, Stein MB, et al. Gender differences in long-term posttraumatic stress disorder outcomes after major trauma: women are at higher risk of adverse outcomes than men. J Trauma 2002; 53 (5): 882-8
43. Frayne SM, Seaver MR, Loveland S, et al. Burden of medical illness in women with depression and posttraumatic stress disorder. Arch Intern Med 2004; 164 (12): 1306-12
44. Zatzick DF, Marmar CR, Weiss DS, et al. Posttraumatic stress disorder and functioning and quality of life outcomes in a nationally representative sample of male Vietnam veterans. Am J Psychiatry 1997; 154 (12): 1690-5
45. Zatzick DF, Weiss DS, Marmar CR, et al. Post-traumatic stress disorder and functioning and quality of life outcomes in female Vietnam veterans. Mil Med 1997; 162 (10): 661-5
46. Albucher RC, Liberzon I. Psychopharmacological treatment in PTSD: a critical review. J Psychiatr Res 2002; 36 (6): 355-67
47. Van Etten ML, Taylor S. Comparative efficacy of treatment for post-traumatic stress disorder: a meta-analysis. Clin Psychol Psychother 1998; 5: 126-44
48. Stein DJ, Ipser J, Seedat S. Pharmacotherapy for post traumatic stress disorder. Cochrane Database Syst Rev 2006; (1): CD002795
49. Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 2001; 58 (5): 485-92
50. Rapaport MH, Endicott J, Clary CM. Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment. J Clin Psychiatry 2002; 63 (1): 59-65
51. Rapaport MH, Pollack M, Wolkow R, et al. Is placebo response the same as drug response in panic disorder? Am J Psychiatry 2000; 157 (6): 1014-6
52. Rapaport MH, Clary CM, Judd LL. The impact of depression and its treatment. Presented at the 154th annual meeting of the American Psychiatric Association; 2001 May 6; New Orleans (LA)
53. Tucker P, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 2001; 62 (11): 860-8
54. Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry 2001; 158 (12): 1982-8
55. McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety 2004; 19 (3): 190-6
56. Boehnlein JK, Kinzie JD, Sekiya U, et al. A ten-year treatment outcome study of traumatized Cambodian refugees. J Nerv Ment Dis 2004; 192: 658-63
57. Weis F, Kilger E, Roozendal B, et al. Stress doss of hydrocortisone reduce chronic stress symptoms and improve health-related quality of life in high-risk patients after cardiac surgery: a randomized study. J Thorac Cardiovasc Surg 2006; 131: 277-82
58. Rothenhausler HB, Grieser B, Nollert G, et al. Psychiatric and psychosocial outcome of cardiac surgery with cardiopulmonary bypass: a prospective 12-month follow-up study. Gen Hosp Psychiatry 2005; 27: 18-28
59. McCrone P, Knapp M, Cawkill P. Posttraumatic stress disorder (PTSD) in the armed forces: health economic considerations. J Trauma Stress 2003; 16 (5): 519-22
60. Meltzer-Brody S, Davidson JR. Completeness of response and quality of life in mood and anxiety disorders. Depress Anxiety 2000; 12 Suppl. 1: 95-101